Skip to Content
77 Mass Ave

Fairer Air

Flight delays can be distributed more equitably among airlines.
October 20, 2015

In 2011, about 20 percent of U.S. flights were at least 15 minutes behind schedule. Such delays irritate passengers, and in 2010 they cost airlines an estimated $6.5 billion.

But Federal Aviation Administration (FAA) rules for managing ground delays and air traffic, which minimize aggregate system delays nationwide, leave some airlines with more delays than others.

Now MIT researchers have developed a new method that would keep system-wide delays virtually constant while distributing the delays more evenly among airlines. They found that letting airlines extensively swap schedule slots with each other—and setting limits on the amount of time any flight could be delayed—is more fair without sacrificing efficiency.

Sloan professor of management Dimitris Bertsimas and Shubham Gupta, SM ’10, PhD ’12, formerly of MIT’s Operations Research Center, tested their model using data from the 55 biggest U.S. airports and the five biggest airlines on six randomly selected days in 2004, 2005, and 2006—more than 30,000 flights in all.

When they simulated what air traffic would have looked like on those six days using their technique, they found that the aggregate delays in the entire system were virtually unchanged. On none of the six days did those totals differ from the actual results by more than 1.0 percent, and the mean difference was 0.1 percent. Bertsimas also notes that the computational side of the proposed system is fast enough to work in real time. A paper detailing the researchers’ findings was published in the journal Transportation Science.

“The price of fairness is small,” says Bertsimas. And that price is well worth it: “If a system is viewed as not fair, it is not stable,” he says.

Keep Reading

Most Popular

This startup wants to copy you into an embryo for organ harvesting

With plans to create realistic synthetic embryos, grown in jars, Renewal Bio is on a journey to the horizon of science and ethics.

VR is as good as psychedelics at helping people reach transcendence

On key metrics, a VR experience elicited a response indistinguishable from subjects who took medium doses of LSD or magic mushrooms.

This nanoparticle could be the key to a universal covid vaccine

Ending the covid pandemic might well require a vaccine that protects against any new strains. Researchers may have found a strategy that will work.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.